跳至主要内容
临床试验/NCT02798601
NCT02798601撤回不适用

Early Induced Hypernatremia for the Prevention and Management of Brain Edema in Patients With Severe Traumatic Brain Injury in a University Hospital

Hospital Pablo Tobón Uribe0 个研究点开始时间: 2017年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
主要终点
Glasgow Outcome Scale Extended

研究概览

简要总结

The purpose of this study is to estimate the effect of an early induced hypernatremia protocol (150-155 milliequivalent/L) versus normonatremia plus mannitol (135 - 145 milliequivalent/L) in terms of neurologic outcome in patients with severe traumatic brain injury managed at critical care unit.

详细描述

Severe traumatic brain injury is one of the main causes of death in young people. Additionally, it is considered a public health problem because of the high prevalence of motor and cognitive dysfunction in those who survive.

One of the cornerstones of management is the control of both intracranial pressure and brain edema. It is indicated to use osmotic active solutions to modulate the transit of fluids from the interstitial to the intracellular space. Not only mannitol but also hypertonic saline acts at this point. Currently there is no evidence in favor or against one of them.

Mannitol has been usually recommended for intracranial pressure control in patients with brain trauma. However, others recommend hypertonic saline to achieve a serum sodium level of 160 milliequivalent/L to modulate brain edema. It is not clear if these therapies have an impact on the neurologic prognosis and how frequently adverse effects occur.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient greater than 14 years old, who suffered severe non-penetrating Brain Trauma (Glasgow Coma Scale (GCS) equal or less than 8) and a motor GCS equal or less than
  • Criteria time: admitted to the Hospital in the first 24 hours of the Brain Trauma (BT) and admitted to ICU in the first 48 hours of brain trauma.
  • Tomographic evidence of brain edema (one of the following criteria: deviation from the midline, obliteration of perimesencephalic cistern or altered cortico-subcortical differentiation).

排除标准

  • Patient with GCS 3 and bilateral mydriatic pupils and unreactive to light, in the presence of hemodynamic stability (systolic blood pressure equal or greater than 90 mmHg).
  • Patient with insipid diabetes at the ICU admission.
  • Patient with limitation of therapeutic effort.
  • Non-neurological Abbreviated Injury Score greater than
  • Patient past medical history of kidney failure, liver disease or heart failure.
  • Serum sodium less than 135 or greater than 150 milliequivalent/L.
  • Terminal disease.
  • No authorization to be enrolled in the trial by the patient's caregiver

结局指标

主要结局

Glasgow Outcome Scale Extended

时间窗: 6 months

The Extended Glasgow Outcome Scale (GOSE) is a global scale for functional outcome that rates patients into eight categories. The categories of severe disability, moderate disability and good recovery are subdivided into a lower and upper category. The scale will be used to evaluate the patient through a phone interview at 6 months of the trauma occurred. The structured interview contains nineteen specific questions which determine upper or lower levels of disability.

次要结局

  • All-cause mortality(28 - day AND 180 - day mortality)
  • Fluid balance.(5 days)
  • Ventilator - Free Days(30 days)
  • Acute kidney injury(7 days)
  • Need of second line therapies for brain edema(7 days)
  • Intracranial pressure (ICP) measurement(5 days)
  • All-cause mortality according to subgroups of monitoring: guided by neurologic examination and serial CT imaging or guided by intracranial pressure monitoring.(28 - day AND 180 - day mortality)
  • Glasgow Outcome Scale Extended (GOSE) according to subgroups of monitoring: guided by neurologic examination and serial CT imaging or guided by intracranial pressure monitoring.(6 Months)

研究者

发起方
Hospital Pablo Tobón Uribe
申办方类型
Other
责任方
Sponsor

相似试验